Asianet Newsable on MSN
Disc Medicine stock slumps after FDA declines approval for inherited disorder drug over efficacy concerns
The FDA said in a letter to the company published on Friday that the data submitted by the company is insufficient proof of clinical benefit for bitopertin.
Prediction markets such as Polymarket and Kalshi let users win money by correctly guessing the outcome of practically any ...
Universities, builders and health trusts are feeling the squeeze, as thinktank says effect of zero net migration could be similar to Brexit ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results